Chitosan (CS), a
natural biopolymer, has been extensively explored
for multiple applications including tissue engineering, gene therapy,
bioimaging, and sewage treatment due to its abundant availability,
intrinsic biocompatibility, biodegradability, and tunable biological
properties. Nevertheless, the actual use of CS is limited because
of its water-insolubility in physiological circumstances, which could
be optimized by chemical modifications via active side groups. Etherification
is one of the most widely used reactions to obtain water-soluble CS
derivatives, such as hydroxybutyl CS (HBC). HBC, synthesized by grafting
hydroxybutyl groups to the functional hydroxyl and amino groups of
CS skeleton, has been demonstrated to possess superior biological
properties over those of CS, especially satisfactory water solubility
in neutral condition and reversible stimulus-response against external
heat. Meanwhile, the unique characteristics of thermally sensitive
“sol–gel” and “sol–micelle”
transition have gained tremendous attention, which differ in heterogeneously
and homogeneously synthesized HBC. Herein, we discuss the synthesis
(heterogeneously and homogeneously) of HBC, favorable physiochemical
properties of HBC, and HBC-centered biocomposites in a range of formulations
or dosage forms such as sponges, gels, nanoparticles, nanofibers,
and films. Meanwhile, we summarize the potential bioapplications and
trends of HBC and HBC centered biocomposites and offer our perspectives
on the plausible advances in this field in the near future.